🔗 Share this article

An underground market for unlicensed slimming drugs is being driven by TikTok fitness influencers and sellers on communication apps, according to new investigations.

Investigational Drug Acquiring Popularity Via Social Media

The experimental drug, which is still in research studies, is being promoted by social media influencers for its supposed weight-reducing effects. Viewers are urged to contact these profiles privately for source information, while also obtaining discount codes.

Active Trade on Messaging Platforms

Additionally, a robust market exists on Telegram, where communities with numerous of members share comparison photos, injection guides and claims of rapid British shipping. Sellers promote the drug there before redirecting buyers to WhatsApp for purchases.

Learning About The Experimental Drug

This medication is an investigational injectable developed by US drugmaker Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could help individuals lose up to 25% of their body weight. Nicknamed the “triple G”, the drug is being hailed digitally as the next Ozempic.

Medical Professionals Express Concerns

However, doctors and pharmacists have warned that the sale of what is still an unlicensed drug in the United Kingdom is a cause for concern and could result in users injecting substances of uncertain source.

Some experts stated the popularity for retatrutide could be linked to the increasing price of licensed slimming products such as Mounjaro.

Regulatory Status and Implementation

Marketing retatrutide on social media or messaging apps is illegal in the United Kingdom, as it is an unapproved medication that cannot be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.

Some influencers try to sidestep the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but advertising and supply can still violate pharmaceutical, marketing, and customer regulations, risking fines, legal action or prison.

Platform Response and Content Removal

Based on the social media company, the service has taken down violative content and banned associated hashtags and search suggestions. The company stated it was dedicated to keeping the service safe and investing in enhancing compliance measures.

Online Trading Activities

Investigations also discovered communities with up to 9,000 members selling retatrutide using Telegram's integrated discovery tool, which operates like a public directory. Typing “retatrutide” instantly displays groups with numerous of users, populated with images of weight loss, positive reviews and step-by-step instructions for preparing or injecting at home.

After moments of joining one group, a vendor posted contact information, where most transactions take place. The seller provided an instruction manual and promised shipping within two days. When questioned whether the product was authentic, one seller responded: “You can’t be sure.” Another provided a photo of a supposed testing documentation. None asked about body mass, medical conditions or past usage.

Product Information and Pricing

Inside these groups, messages show black plastic parcels with Royal Mail stickers, claiming to contain new batches. One communication read: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, mixed at residence with purified liquid, or pre-filled pens typically sold at 160 pounds for 20mg. When asked how long a pen should be used, vendors give contradictory answers varying between a few weeks to “depends on your body”.

Service Moderation and Safety Actions

A representative for Telegram stated it actively moderated harmful material on its service including content that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Cautions

“People are injecting substances they can’t verify. Although the research behind this drug is valid, these digital versions may not contain what they claim,” said Jason Murphy, the head of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor linked the increase in interest to current price rises for approved slimming medications such as Mounjaro. “With costs increasing, individuals are using social media. But fake injections are extremely dangerous. You can’t be certain what’s inside or whether the environment they were produced in was clean,” she explained.

Her team has already seen individuals injured by self-injection from unconfirmed sources. “We recognize the frustration, but purchasing from Telegram or WhatsApp is gambling with your health,” stated Wyllie. “These materials could be impure or improperly measured.”

Producer Statement

A spokesperson from Eli Lilly said retatrutide was in phase 3 research studies and had not been evaluated or approved by any government authority globally. “Therefore at this point no one can market [it] for personal consumption,” they said, adding that any item “falsely representing itself as a Lilly investigational substance not yet authorized … may subject users to possibly serious medical dangers”.